Results 271 to 280 of about 100,051 (354)

Olof Bäckman & Håkan Leifman: Alcohol and psychotropic drugs - A time series analysis

, 1993

openalex   +1 more source

The prevalence and correlates of self‐reported cannabis use for medicinal, dual and recreational motives in Australia: Findings from the National Drug Strategy Household Survey 2022/2023

Drug and Alcohol Review, EarlyView.
Abstract Introduction Cannabis has been prescribed as a medicine in Australia since 2016. The current study aimed to conduct a descriptive, epidemiological investigation on the prevalence and correlates of cannabis use for different motives (recreational‐only, medical‐only or dual‐use) in Australia.
Danielle Dawson, Gary Chan, Daniel Stjepanović, Valentina Lorenzetti, Wayne D. Hall, Janni Leung   +5 more
wiley   +1 more source

Editorial: Crosstalk within neurovascular unit: endothelial implications for the development and function of brain

Frontiers in Cellular Neuroscience
Kunwei Wu, Shumin Gong, Xiang-Ping Chu
doaj   +1 more source

Part II: Cardiac drug and psychotropic drug interactions: significance and recommendations

, 1999
James J. Strain, Gina Caliendo, Jeffrey D. Alexis, R.Sandlin Lowe, Anwarul Karim, Mark Loigman   +5 more
openalex   +1 more source

Contents and Time‐Course of Falsified Alprazolam Detections in New South Wales, Australia

Drug and Alcohol Review, EarlyView.
ABSTRACT Introduction Falsified alprazolam tablets (sometimes called ‘counterfeit alprazolam’) typically do not contain alprazolam and instead contain novel benzodiazepines or other drugs. We describe temporal changes in the number and contents of falsified alprazolam tablets in New South Wales, Australia.
Janette L. Smith, Thanjira Jiranantakan, Una Cullinan, Christopher Ewers, Darren M. Roberts, Jared A. Brown   +5 more
wiley   +1 more source

Association between Prescribing and Intoxication Rates for Selected Psychotropic Drugs: A Longitudinal Observational Study. [PDF]

Pharmaceuticals (Basel)
Dobravc Verbič M, Grabnar I, Brvar M.
europepmc   +1 more source

The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.

, 1995
Judith Garrard, Vienna Chen, Bryan Dowd
openalex   +1 more source

A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?

Drug and Alcohol Review, EarlyView.
ABSTRACT Issues Rising synthetic opioid deaths in North America, and the emergence of nitazene harms has driven concern about novel synthetic opioids (NSO) in Australia. This scoping review aimed to map what is known about NSOs in Australia. Approach Scoping review of peer‐reviewed and grey literature on NSO detections and harms.
Emmanuel Mammoliti, Suzanne Nielsen, Amanda Roxburgh   +2 more
wiley   +1 more source